FIRST AIRED: May 23, 2017

Nice work! Enjoy the show!

×

You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!

×

Transcript

00:00:00
and industrial die developed over a hundred years ago could be a new weapon against cancer , and now they're testing it's melanoma they're injecting this bright red liquid right into melanoma lesions and tumors and they've seen some , very promising early results , half of the patients who had every lesion injected experience to complete response , meaning no signs of cancer , a year later eleven percent of them remained apparently cancer free , it did not meet FDA approval it could be on the market by twenty nineteen , its long history as a common will die means it could be sold relatively cheaply , but protected executives hope to sell the company if the treatment is approved meaning another firm will likely determine the drug's price going to say look we've got this really interesting new melanoma treatment that you know we can charge relatively and we're left for , John melanoma researchers say the treatment shows promise for treating cancer elsewhere in the body as well